Zenas BioPharma (ZBIO) Financials: Revenue & Earnings

ZBIO price $28.45 +1.15 +4.21%

Ticker
ZBIO
Price
$28.45
Change
+1.15 +4.21%
Market cap ?
$1.85B
P/E ?
-2.93
Dividend yield ?
0.00%
Beta ?
-1.02
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
47
Value
52
Quality
39
Growth
49

Stocklytics score rationale: value 52, quality 39, growth 49.

Financials

2022202320242025
050000000500000010000000

Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and…

Fair value

ZBIO fair value Not meaningful. Price $28.45.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ZBIO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-04-12—-1.20—1.59M
2026-11-18—-1.24—1.01M
2026-08-12-1.77-1.121.00M15.00M
2026-05-13-1.46-1.37—25.00M
2026-03-16-4.54-1.06—13.33M
2025-11-12-1.22-0.87—28.75M
2025-08-12-1.25-1.02—3.75M
2025-05-15-0.80-1.1110.00M1.25M
2025-04-01-1.26-0.925.00M—
2024-11-12-5.02-9.33——
2024-08-22-1.24———
2024-03-31-0.73———
2023-12-31-0.64———
2023-09-300.85—50.00M—
2023-06-30-0.76———
2023-03-31-0.50———
2022-12-31-0.50———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-01Oliger Christy J.Buy37.00K$31.981.18M
2026-09-01Oliger Christy J.Other0——
2026-08-26InnoCare Pharma Inc.Other0——
2026-06-15Nunn Jason RaleighBuy18.50K$18.71346.13K
2026-06-15Lu HongboBuy18.50K$18.71346.13K
2026-06-15MOULDER LEON O JRBuy500.00K$18.719.36M
2026-06-15ORLOFF JOHN JBuy18.50K$18.71346.13K
2026-06-15von Moltke LisaBuy150.00K$18.712.81M
2026-06-15Allen Patricia LBuy18.50K$18.71346.13K
2026-06-15Boylan James PBuy18.50K$18.71346.13K
2026-06-15ENRIGHT PATRICK GBuy18.50K$18.71346.13K
2026-06-15Farmer Joseph LBuy175.00K$18.713.27M
2026-06-15Fox Jennifer A.Buy125.00K$18.712.34M
2026-05-18MOULDER LEON O JRBuy60.00K$16.881.01M
2026-04-29MOULDER LEON O JRBuy35.00K$17.62616.70K
2026-04-28MOULDER LEON O JRBuy25.00K$18.02450.50K
2026-03-31Lu HongboBuy3.77K$18.6370.20K
2026-03-31Fairmount Funds Management LLCBuy150.00K$20.003.00M
2026-03-31MOULDER LEON O JRBuy34.00K$19.31656.54K
2026-03-31Lu HongboBuy75.00K$20.001.50M
2026-03-30MOULDER LEON O JRBuy20.00K$18.23364.60K
2026-02-13Allen Patricia LBuy4.16K$26.36109.66K
2026-02-12Allen Patricia LBuy5.00K$26.50132.50K
2026-02-12Allen Patricia LBuy5.70K$24.34138.74K
2026-02-12Allen Patricia LBuy5.00K$23.77118.85K
2026-02-11Lu HongboBuy25.98K$22.50584.66K
2026-02-05Farmer Joseph LBuy974$13.3513.00K
2026-02-05Fox Jennifer A.Buy1.59K$13.3521.25K
2026-02-02MOULDER LEON O JRBuy57.00K$17.961.02M
2026-01-09MOULDER LEON O JRBuy20.00K$16.55331.00K
2026-01-08MOULDER LEON O JRBuy30.00K$16.30489.00K
2026-01-07MOULDER LEON O JRBuy50.00K$16.38819.00K
2025-10-09Nunn Jason RaleighBuy63.16K$19.001.20M
2025-10-09SR ONE CAPITAL MANAGEMENT, LLCBuy63.16K$19.001.20M
2025-10-09SR ONE CAPITAL MANAGEMENT, LLCBuy63.16K$19.001.20M
2025-10-09ENRIGHT PATRICK GBuy105.27K$19.002.00M
2025-10-09ENRIGHT PATRICK GBuy11.99K$20.85249.99K
2025-10-07InnoCare Pharma Inc.Other0——
2025-10-07MOULDER LEON O JRBuy36.93K$20.85769.95K
2025-10-07Fairmount Funds Management LLCBuy316.22K$19.006.01M
2025-10-07Lu HongboBuy263.16K$19.005.00M
2025-06-10Nunn Jason RaleighBuy18.50K$11.94220.89K
2025-06-10Fox Jennifer A.Buy150.00K$11.941.79M
2025-06-10Oliveira OrlandoBuy100.00K$11.941.19M
2025-06-10Boylan James PBuy18.50K$11.94220.89K
2025-06-10Allen Patricia LBuy18.50K$11.94220.89K
2025-06-10Farmer Joseph LBuy175.00K$11.942.09M
2025-06-10Fairmount Funds Management LLCBuy18.50K$11.94220.89K
2025-06-10ENRIGHT PATRICK GBuy18.50K$11.94220.89K
2025-06-10ORLOFF JOHN JBuy18.50K$11.94220.89K
2025-06-10Lu HongboBuy18.50K$11.94220.89K
2025-06-10MOULDER LEON O JRBuy400.00K$11.944.78M
2025-04-15von Moltke LisaBuy400.00K$8.723.49M
2025-03-17von Moltke LisaOther0——
2025-02-18MOULDER LEON O JRBuy25.00K$6.67166.75K
2025-02-07Xiao TingBuy10.00K$7.7677.60K
2025-02-07Xiao TingBuy10.00K$7.7677.60K
2024-12-16Fox Jennifer A.Buy8.12K$8.7771.26K
2024-12-16Oliveira OrlandoBuy7.78K$8.7768.19K
2024-12-04MOULDER LEON O JRBuy45.00K$9.98449.10K
2024-12-03MOULDER LEON O JRBuy25.00K$10.76269.00K
2024-11-19MOULDER LEON O JRBuy2.50K$14.5736.42K
2024-11-18MOULDER LEON O JRBuy7.50K$15.00112.50K
2024-09-20MOULDER LEON O JRBuy2.63K$18.9749.95K
2024-09-20MOULDER LEON O JRBuy2.37K$17.8842.32K
2024-09-19MOULDER LEON O JRBuy5.00K$17.8989.45K
2024-09-18MOULDER LEON O JRBuy10.00K$17.91179.10K
2024-09-16Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Buy200.72K——
2024-09-16Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Buy420.27K——
2024-09-16Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Buy180.63K——
2024-09-16Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Sell3.65M——
2024-09-16Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Sell1.57M——
2024-09-16Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Sell1.74M——
2024-09-16Enavate Sciences GP, LLCBuy882.35K$17.0015.00M
2024-09-16Enavate Sciences GP, LLCBuy2.88M——
2024-09-16Enavate Sciences GP, LLCSell10.47M——
2024-09-16Enavate Sciences GP, LLCSell14.52M——
2024-09-16Fairmount Funds Management LLCBuy300.00K$17.005.10M
2024-09-16Fairmount Funds Management LLCBuy301.08K——
2024-09-16Fairmount Funds Management LLCBuy709.79K——
2024-09-16Fairmount Funds Management LLCBuy252.89K——
2024-09-16Fairmount Funds Management LLCBuy41.13K——
2024-09-16Fairmount Funds Management LLCSell2.61M——
2024-09-16Fairmount Funds Management LLCSell6.16M——
2024-09-16Fairmount Funds Management LLCSell357.14K——
2024-09-16Fairmount Funds Management LLCSell2.20M——
2024-09-16MOULDER LEON O JRBuy372.02K——
2024-09-16MOULDER LEON O JRBuy164.52K——
2024-09-16MOULDER LEON O JRBuy48.25K——
2024-09-16MOULDER LEON O JRBuy108.38K——
2024-09-16MOULDER LEON O JRSell1.43M——
2024-09-16MOULDER LEON O JRSell941.09K——
2024-09-16MOULDER LEON O JRSell419.00K——
2024-09-16ENRIGHT PATRICK GBuy1.00M——
2024-09-16ENRIGHT PATRICK GBuy440.00K$17.007.48M
2024-09-16ENRIGHT PATRICK GBuy723.81K——
2024-09-16ENRIGHT PATRICK GBuy334.53K——
2024-09-16ENRIGHT PATRICK GSell6.28M——
2024-09-16ENRIGHT PATRICK GSell2.90M——
2024-09-16Nunn Jason RaleighBuy441.18K$17.007.50M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 151, holders +6 vs prior quarter. Ownership 110.69%.

HolderSharesChangeChange %Value
FMR LLC9.51M424.70K+4.68%241.28M
SR ONE CAPITAL MANAGEMENT, LP5.04M00.00%127.86M
NEA MANAGEMENT COMPANY, LLC4.02M00.00%102.11M
ENAVATE SCIENCES GP, LLC3.92M00.00%99.47M
FEDERATED HERMES, INC.3.12M-10.23K-0.33%79.10M
BLACKROCK, INC.2.69M648.68K+31.84%68.18M
CAPITAL INTERNATIONAL INVESTORS2.50M68.91K+2.83%63.52M
POLAR CAPITAL HOLDINGS PLC2.41M-135.67K-5.32%61.24M
ROYALTY PHARMA SUB-MANAGER, LLC2.39M00.00%60.61M
FAIRMOUNT FUNDS MANAGEMENT LLC2.36M00.00%59.87M
STATE STREET CORP2.06M584.18K+39.71%52.16M
NVP ASSOCIATES, LLC1.84M00.00%46.66M
WELLINGTON MANAGEMENT GROUP LLP1.59M347.77K+27.91%40.45M
VANGUARD CAPITAL MANAGEMENT LLC1.35M109.47K+8.79%34.39M
BANK OF AMERICA CORP /DE/1.23M842.81K+217.03%31.25M
PRICE T ROWE ASSOCIATES INC /MD/1.23M869.66K+243.42%31.14M
GEODE CAPITAL MANAGEMENT, LLC882.65K226.87K+34.60%22.41M
ALLIANCEBERNSTEIN L.P.1.10M206.07K+22.96%21.57M
TWO SIGMA INVESTMENTS, LP815.15K540.09K+196.36%20.69M
ECOR1 CAPITAL, LLC789.50K00.00%20.04M
MILLENNIUM MANAGEMENT LLC660.47K183.65K+38.52%16.76M
WOODLINE PARTNERS LP590.54K14+0.00%14.99M
BALYASNY ASSET MANAGEMENT L.P.576.72K-90.35K-13.54%14.64M
ARROWMARK COLORADO HOLDINGS LLC573.32K-85.59K-12.99%14.55M
SILVERARC CAPITAL MANAGEMENT, LLC509.79K-626.15K-55.12%12.94M

Earnings and financials

Zenas BioPharma, Inc. (ZBIO) trades at $28.45, with a market cap of $1.85B and a trailing P/E of -2.93. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2022202320242025
050000000500000010000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Zenas BioPharma (ZBIO) Financials: Revenue & Earnings

ZBIO$28.45+1.15 +4.21%

$1.85B

Market Cap

-2.93

P/E

—

Forward P/E

47

Score

Price History